Jim Cramer discusses one group of stocks that has become totally overcrowded and issues a warning to steer clear of the bottom-feeders.» Read More
Sluggishness in the chipmaker's personal computer segment was partially offset by strong growth in its data center business.
From the looks of the bond market, you might think the economy was heading south—and fast.
Take a look at some of Tuesday's after-hours buzz: Intel, Biogen & more
Data from the IRS shows that middle class Americans too are finding ways to benefit from capital gains.
Avon is considering a possible sale of its North American business as it explores strategic alternatives, The Wall Street Journal reports.
One options trader is betting that General Electric will hold its recent gains for the next several months.
Thirteen stocks in the S&P 500 are not doing as well since the market peaked in early March; they are either falling or still. The USA Today reports.
CNBC's Jim Cramer says J.C. Penney's expected same-store sales projection is good, but ...
When Intel reports earnings after the bell Tuesday, investors will have a better sense of where the PC market is headed.
A potential head and shoulders pattern is forming in the Nasdaq Composite – which could be signaling a reversal.
Lofty valuations in both bonds and stocks are seen as one of the biggest risks for markets, a fund manager poll has shown.
These beaten-down names could have much more upside ahead, say traders.
As investors brace for what could be the first quarter of negative earnings in six years, CNBC Pro found some of the names that could buck that trend.
Some of the names on the move ahead of the open.
Jim Cramer saw one deal last week that is just getting the pot stirred on Wall Street. Could more LBOs be headed our way?
The "Fast Money" traders give their final trades of the day.
Most of us aren't the target of IRS examiners. The tax collector has been focusing on the rich.
Jim Cramer has seen the new face of activism, which means a whole new approach to stocks. This activist is right on the money right now.
How traders are assessing Wells Fargo and JPMorgan ahead of earnings.
The battle between activist investor Trian and DuPont is heating up ahead of a proxy vote for new board members.